Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution To Australia

2026-02-26 - 21:34

OXFORD, England, Feb. 27, 2026 /PRNewswire/ -- Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration (TGA) class IIb approval in Australia for the Virtual Nodule Clinic (VNC)...